and 62% not receiving systemic therapy. 3 – 7 Multiagent systemic therapies can nevertheless improve survival and reduce symptom burden within this patient population. 8 – 10 Therefore, a need exists to ensure that opportunities for treatment are
Search Results
Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis
Elliott K. Yee, Natalie G. Coburn, Laura E. Davis, Alyson L. Mahar, Victoria Zuk, Vaibhav Gupta, Ying Liu, Craig C. Earle, and Julie Hallet
Guidelines for the Management of Breakthrough Pain in Patients With Cancer
Augusto Caraceni, Andrew Davies, Philippe Poulain, Hernán Cortés-Funes, Sunil J. Panchal, and Guido Fanelli
. The continuity of care and a gradual transition to palliative care should always be considered in the presence of advanced disease and significant symptom burden. Describe in full the pain characteristics, including intensity and other clinically
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments
J. Matt McCrary, David Goldstein, Terry Trinh, Hannah C. Timmins, Tiffany Li, Jasmine Menant, Michael Friedlander, Craig R. Lewis, Mark Hertzberg, Siobhan O’Neill, Tracy King, Annmarie Bosco, Michelle Harrison, and Susanna B. Park
a 20-item questionnaire related to sensory, motor, and autonomic symptoms of neuropathy. A higher score on this questionnaire represents increased symptom burden, with each item scored from 1 (not at all) to 4 (very much), and the total questionnaire
Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial
Sriram Yennurajalingam, Vicente Valero, Zhanni Lu, Diane D. Liu, Naifa L. Busaidy, James M. Reuben, Carolina Diaz Fleming, Janet L. Williams, Kenneth R. Hess, Karen Basen-Engquist, and Eduardo Bruera
2000 ; 88 : 2164 – 2171 . 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5 10813730 23. Cheung WY , Barmala N , Zarinehbaf S , The association of physical and psychological symptom burden with time to death among
Adolescents and Young Adults Living With an Uncertain or Poor Cancer Prognosis: The “New” Lost Tribe
Vivian W.G. Burgers, Winette T.A. van der Graaf, Daniël J. van der Meer, Martin G. McCabe, Anita W. Rijneveld, Martin J. van den Bent, and Olga Husson
accompanied by continuing issues, such as symptom burden and treatment-related adverse effects, which result in loss of independence and cause AYAs to become increasingly dependent on their informal caregivers for physical, emotional, and financial support. 8
Psychostimulants for Cancer-Related Fatigue
William Breitbart and Yesne Alici
-being was associated with placebo response. The researchers hypothesized that patients with worse baseline fatigue may have had a greater desire for effect and also increased expectations of improvement given their higher symptom burden. The researchers
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies
Elio Mazzone, Sophie Knipper, Francesco A. Mistretta, Carlotta Palumbo, Zhe Tian, Andrea Gallina, Derya Tilki, Shahrokh F. Shariat, Francesco Montorsi, Fred Saad, Alberto Briganti, and Pierre I. Karakiewicz
, Shete S , . Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks . Cancer 2012 ; 118 : 856 – 863 . 21751190 10.1002/cncr.26312 28. Necchi
Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer
Courtney P. Williams, Andres Azuero, Kelly M. Kenzik, Maria Pisu, Ryan D. Nipp, Smita Bhatia, and Gabrielle B. Rocque
as medication nonadherence, high symptom burden, and poor quality of life. 7 , 8 Older adults (aged ≥65 years) are particularly vulnerable to financial toxicity, because they often live on a fixed income and therefore could be financially and
Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
Natalie Moryl, Tito R. Mendoza, Susan D. Horn, Jelyn C. Eustaquio, Charles S. Cleeland, and Charles Inturrisi
may significantly overestimate opioid misuse. As a result, this tool has been retired from our institution’s standard PROs. Conclusions COMM ≥13 in our patient population may be diagnosing a greater symptom burden of cancer and predicting
Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic Breast Cancer
Joseph A. Greer, Beverly Moy, Areej El-Jawahri, Vicki A. Jackson, Mihir Kamdar, Juliet Jacobsen, Charlotta Lindvall, Jennifer A. Shin, Simone Rinaldi, Heather A. Carlson, Angela Sousa, Emily R. Gallagher, Zhigang Li, Samantha Moran, Magaret Ruddy, Maya V. Anand, Julia E. Carp, and Jennifer S. Temel
documentation of advance care plans and earlier referral to hospice before death. 12 – 17 National organizations now recommend early PC for patients with advanced cancer and/or high symptom burden. 18 , 19 For patients with MBC, many of whom have long disease
